These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 4770124

  • 1. Combined therapeutic trial in multiple sclerosis: hydrocortisone hemisuccinate with cyclophosphamide or cytosine arabinoside.
    Cendrowski W.
    Acta Neurol Belg; 1973; 73(4):209-19. PubMed ID: 4770124
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of multiple sclerosis with intravenous hydrocortisone hemisuccinate in combination with cyclophosphamide or cytosine arabinoside].
    Cendrowski W.
    Neurol Neurochir Pol; 1974; 8(1):47-52. PubMed ID: 4407711
    [No Abstract] [Full Text] [Related]

  • 3. [Intensive immunosuppressive treatment of chronic progressive multiple sclerosis].
    Hommes OR.
    Ned Tijdschr Geneeskd; 1978 Oct 14; 122(41):1545-51. PubMed ID: 358004
    [No Abstract] [Full Text] [Related]

  • 4. Immunosuppressive therapy in neurological diseases.
    Cendrowski W, Riekkinen PJ, Rinne UK.
    Ann Clin Res; 1974 Dec 14; 6(6):323-9. PubMed ID: 4375431
    [No Abstract] [Full Text] [Related]

  • 5. Immunosuppressive treatment of multiple sclerosis.
    Hadaway LC.
    NITA; 1985 Dec 14; 8(6):503-5. PubMed ID: 2999647
    [No Abstract] [Full Text] [Related]

  • 6. Multiple sclerosis: pilot therapeutic trial of immunosuppressants.
    Cendrowski WS.
    Schweiz Arch Neurol Neurochir Psychiatr; 1969 Dec 14; 105(2):241-6. PubMed ID: 4314087
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
    Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, Garrido Ed Ede R, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gül A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R.
    Arthritis Rheum; 2002 Aug 14; 46(8):2121-31. PubMed ID: 12209517
    [Abstract] [Full Text] [Related]

  • 14. [Immunosuppressive therapy in rheumatoid arthritis].
    Weigl E, Lehmann G, Krieg D.
    Z Gesamte Inn Med; 1971 Sep 01; 26(17):561-3. PubMed ID: 5125160
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.